Authors' Response to "TB Prevalence in People Tested is a Strong Predictor of Xpert Specificity in Community and Risk Group Screening".

Veeken LD, Horton KC, Houben RMGJ

Open source

DOI
10.1093/infdis/jiaf419
Published
2025 Dec 20
Container
The Journal of infectious diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/infdis/jiaf419,
  title = {Authors' Response to "TB Prevalence in People Tested is a Strong Predictor of Xpert Specificity in Community and Risk Group Screening".},
  author = {Veeken LD and Horton KC and Houben RMGJ},
  year = {2025},
  journal = {The Journal of infectious diseases},
  doi = {10.1093/infdis/jiaf419},
  url = {https://doi.org/10.1093/infdis/jiaf419}
}

RIS

TY  - JOUR
TI  - Authors' Response to "TB Prevalence in People Tested is a Strong Predictor of Xpert Specificity in Community and Risk Group Screening".
AU  - Veeken LD
AU  - Horton KC
AU  - Houben RMGJ
PY  - 2025
JO  - The Journal of infectious diseases
DO  - 10.1093/infdis/jiaf419
UR  - https://doi.org/10.1093/infdis/jiaf419
ER  - 

APA

LD, V., KC, H., & RMGJ, H. (2025). Authors' Response to "TB Prevalence in People Tested is a Strong Predictor of Xpert Specificity in Community and Risk Group Screening".. The Journal of infectious diseases. https://doi.org/10.1093/infdis/jiaf419

Source records